Urovant Sciences gets USFDA nod for once-daily 75 mg vibegron for overactive bladder Medical Dialogues Bureau9 March 2020 6:56 AMIRVINE -Urovant Sciences has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application...
Strides Pharma gets USFDA nod for generic version of Vesicare Tablets to treat overactive bladder Medical Dialogues Bureau28 Sept 2019 9:08 AM"Solifenacin Succinate Tablet is a generic version of Vesicare Tablets, 5 mg and 10 mg, of Astellas Pharma US, Inc, " Strides Pharma said.Bangalore:...
Lupin gets tentative USFDA nod for generic version of Mirabegron ER tablets Farhat Nasim28 Jun 2019 5:40 AMThe approval by the US Food and Drug Administration (USFDA) is for a generic version of Mirabegron ER tablets of strengths 25 mg and 50 mg, Lupin said...
Zydus Cadila gets tentative USFDA nod for Mirabegron ER tablets to treat overactive bladder Farhat Nasim2 April 2019 6:20 AMThe company has received tentative approval from the United States Food and Drug Administration (USFDA) to market generic Mirabegron extended-release...
Zydus gets USFDA nod for overactive bladder drug Ruby Khatun Khatun6 Oct 2017 4:19 AMNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market capsules used in treating overactive...
